PainReform is a pharmaceutical company that develops products for the treatment of pain. Its extended release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. PainReform's key product is PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized post-operative analgesia.